Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Feb 11;10(4):e43. doi: 10.1016/S2213-2600(22)00057-1

Correction to Lancet Respir Med 2022; 10: 327–36

PMCID: PMC8837205  PMID: 35157835

Ely EW, Ramanan AV, Kartman CE, et al. Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial. Lancet Respir Med 2022; published online Feb 3. https://doi.org/10.1016/S2213-2600(22)00006-6—In this Article, some of the percentages in table 1 were incorrect and have been updated. These corrections have been made to the online version as of Feb 11, 2022, and will be made to the printed version.


Articles from The Lancet. Respiratory Medicine are provided here courtesy of Elsevier

RESOURCES